More Than 75 Companies Adopt Veeva Vault CTMS to Accelerate Clinical Research
Summary
BARCELONA, Spain--(BUSINESS WIRE)--As the need to improve efficiency and speed in trials grows, more than 75 organizations, including six of the top 20 pharmaceutical companies, are unifying clinical information and processes with Veeva Vault CTMS. More emerging biotechs and global organizations have adopted the modern cloud application from Veeva Systems (NYSE: VEEV) for greater visibility and faster execution in trials. “The widespread use of siloed systems and spreadsheets to manage clinical trials have been slowing down studies for years,” said Henry Galio, senior director, Veeva Vault CTMS. Over the last year, Veeva has added new capabilities to help customers proactively manage trials and adapt quickly to changes, including: • Vault Payments, an application to manage the payment and reimbursement of research sites; • Seamless integration with Veeva Vault EDC for improved visibility and reporting; • The ability for CRAs to quickly and easily author monitor trip reports for improved productivity and efficiency. AstraZeneca discusses the positive impact of a unified clinical landscape on global study execution at the Veeva R&D and Quality Summit, register for the on-demand session at veeva.com/rdsummit.
Classifications
AskAI Classifications
LabelsLinked Companies
